Product

COVAXIN(BBV152)

1 clinical trial

1 indication

Indication

Coronavirus Infection

Clinical trial

Phase 2 Randomized, Multi-centric of Heterologus Prime-Boost Combination of SARS-CoV-2 Vaccines to Evaluate the Immunogenicity and Safety of BBV152 (COVAXIN®) With BBV154 (Adenoviral Intranasal COVID-19 Vaccine) in Healthy Volunteers

Status: Completed, Estimated PCD: 2022-03-01